1. Home
  2. LRMR vs DDD Comparison

LRMR vs DDD Comparison

Compare LRMR & DDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LRMR
  • DDD
  • Stock Information
  • Founded
  • LRMR N/A
  • DDD 1986
  • Country
  • LRMR United States
  • DDD United States
  • Employees
  • LRMR N/A
  • DDD N/A
  • Industry
  • LRMR Biotechnology: Pharmaceutical Preparations
  • DDD Computer peripheral equipment
  • Sector
  • LRMR Health Care
  • DDD Technology
  • Exchange
  • LRMR Nasdaq
  • DDD Nasdaq
  • Market Cap
  • LRMR 204.9M
  • DDD 210.1M
  • IPO Year
  • LRMR N/A
  • DDD N/A
  • Fundamental
  • Price
  • LRMR $3.88
  • DDD $1.79
  • Analyst Decision
  • LRMR Strong Buy
  • DDD Hold
  • Analyst Count
  • LRMR 7
  • DDD 3
  • Target Price
  • LRMR $17.86
  • DDD $3.50
  • AVG Volume (30 Days)
  • LRMR 892.3K
  • DDD 3.3M
  • Earning Date
  • LRMR 08-06-2025
  • DDD 08-28-2025
  • Dividend Yield
  • LRMR N/A
  • DDD N/A
  • EPS Growth
  • LRMR N/A
  • DDD N/A
  • EPS
  • LRMR N/A
  • DDD N/A
  • Revenue
  • LRMR N/A
  • DDD $431,756,000.00
  • Revenue This Year
  • LRMR N/A
  • DDD N/A
  • Revenue Next Year
  • LRMR N/A
  • DDD $3.55
  • P/E Ratio
  • LRMR N/A
  • DDD N/A
  • Revenue Growth
  • LRMR N/A
  • DDD N/A
  • 52 Week Low
  • LRMR $1.61
  • DDD $1.32
  • 52 Week High
  • LRMR $9.88
  • DDD $5.00
  • Technical
  • Relative Strength Index (RSI)
  • LRMR 69.65
  • DDD 53.32
  • Support Level
  • LRMR $3.11
  • DDD $1.60
  • Resistance Level
  • LRMR $4.01
  • DDD $2.17
  • Average True Range (ATR)
  • LRMR 0.27
  • DDD 0.13
  • MACD
  • LRMR 0.03
  • DDD 0.02
  • Stochastic Oscillator
  • LRMR 85.64
  • DDD 34.14

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

About DDD 3D Systems Corporation

3D Systems Corp provides comprehensive 3D printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, and services, including maintenance, advanced manufacturing and applications engineering. The company's segments include Healthcare Solutions and Industrial Solutions. It generates maximum revenue from the Industrial segment. It conducts business through various offices and facilities located throughout the Americas, EMEA, and APAC; generating a vast majority of revenues from the Americas.

Share on Social Networks: